Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:January 5, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:January 5, 2021Completed
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:February 13, 2024Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:June 10, 2022Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 18, 2024Active, not recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:February 21, 2024Recruiting
Condition(s):Neovascular Age-related Macular Degeneration (nAMD)Last Updated:November 13, 2023Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 30, 2024Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:March 26, 2024Active, not recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:August 24, 2023Recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:March 1, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.